Two Sigma Securities’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Two Sigma Securities’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-14,300	Closed	-$223K	–	1623
2020 Q4	$223K	Buy	+14,300	New	+$168K	0.01%	1305

Other funds holding SGMO

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

AIM

Axiom Investment Management New York $150M AUM

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Two Sigma Securities's SGMO Position: Q2 2026 in Review

Two Sigma Securities sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 60,102 shares — an estimated $14.8K sold.

Two Sigma Securities first reported a position in SGMO in Q4 2016 and held it in 6 quarters. The position peaked at $177K in Q2 2019. 6 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Two Sigma Securities reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
Two Sigma Securities sold 60,102 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $14.8K.
Two Sigma Securities first reported a position in SANGAMO THERAPEUTICS INC in Q4 2016 and held it in 6 quarters.
Two Sigma Securities's SANGAMO THERAPEUTICS INC position peaked at $177K in Q2 2019.
6 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.